Joseph McKendrick

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Chris Twelves, A. Wong, Marek P. Nowacki et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

Randomized Trial of Short-Course Radiotherapy Versus Long-Course Chemoradiation Comparing Rates of Local Recurrence in Patients With T3 Rectal Cancer: Trans-Tasman Radiation Oncology Group Trial 01.04

Samuel Y. Ngan, Bryan Burmeister, Richard Fisher et al. · Journal of Clinical Oncology · 2012 · 908 citations

Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer

Jeanne Tie, Joshua D. Cohen, Yuxuan Wang et al. · JAMA Oncology · 2019 · 665 citations · Full text

Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients

Hans‐Joachim Schmoll, Thomas H. Cartwright, Josep Tabernero et al. · Journal of Clinical Oncology · 2006 · 296 citations

Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: Prespecified subgroup analyses from the VELOUR trial

Josep Tabernero, Eric Van Cutsem, Radek Lakomý et al. · European Journal of Cancer · 2013 · 236 citations · Full text